Pulmonary fibrosis in post-COVID-19: epithelial-mesenchymal transition as a key mechanism and target for therapy
Inflammopharmacology · 2026
DOI: 10.1007/s10787-025-02074-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2026. Verfasst von R Sanjay Ramanan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Pulmonary Fibrosis, COVID-19. Die Arbeit nennt 97 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Pulmonary fibrosis is a serious threat to global health, especially in after math of covid-19 infection, eventually results in fibrotic remodeling and organ damage. This SARS-CoV 2 induced fibrosis initiates cascade of proinflammatory responses such as cytokine release. EMT (Epithelial-mesenchymal transition) is a central event in post COVID 19 pulmonary fibrosis which is characterized by the accumulation of stimulated fibroblast and myoblast, finally epithelial morphology changed to mesenchymal traits. This transformation is marked by the loss of intercellular adhesion and polarity. A study of SARS-CoV 2 pathogenesis and EMT can provide insights to pulmonary fibrosis. Hence identification of biomarkers of EMT activation helps early diagnosis and determination of therapeutic approaches against pathogenesis. This review focusing on the mechanism of post-covid 19 pulmonary fibrosis through EMT with a special importance to TGF-β/Smad, NF-κB pathways and oxidative stress. Previous studies marked the EMT induced fibronectin, collagen deposition that can potentially disrupt lung structure and its function. SARS CoV 2 infection can trigger Hyper activation of profibrotic pathways like TGF-β/Smad, NF-κB pathways that maintain EMT via downregulation of E-Cadherin and upregulation of vimentin, fibronectin and α-SMA. SARS-CoV spike-protein binds to AEC-2 cells initiates cytokine storm followed by amplified NF-κB pathway, and oxidative stress. Elevated activation of this pathway increases Snail, Slug, Twist expression that leads to EMT. Moreover, increased ROS production creates fibrotic environment in lung. This review examined the mechanism behind the pulmonary fibrosis by analyzing interplay between the SARS-CoV 2 infection and EMT, providing effective therapeutic strategies to prevent EMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Biology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
- Cancer Biology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. ravikumarbdu@gmail.com.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Ramanan, R. S., Kesavan, K. V., & Ravikumar, V. (2026). Pulmonary fibrosis in post-COVID-19: epithelial-mesenchymal transition as a key mechanism and target for therapy. Inflammopharmacology. https://doi.org/10.1007/s10787-025-02074-5
Vancouver
Ramanan RS, Kesavan KV, Ravikumar V. Pulmonary fibrosis in post-COVID-19: epithelial-mesenchymal transition as a key mechanism and target for therapy. Inflammopharmacology. 2026. doi:10.1007/s10787-025-02074-5
BibTeX
@article{Ramanan2026,
author = {Ramanan, R Sanjay and Kesavan, Krishnaja V and Ravikumar, Vilwanathan},
title = {Pulmonary fibrosis in post-COVID-19: epithelial-mesenchymal transition as a key mechanism and target for therapy},
journal = {Inflammopharmacology},
year = {2026},
doi = {10.1007/s10787-025-02074-5}
}
EUVIMED